Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

NCT01099449 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

362

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapeutic Agent Toxicity
Colorectal Cancer
Neuropathy
Neurotoxicity

Interventions

DRUG: calcium gluconate
DRUG: magnesium sulfate
OTHER: placebo
DRUG: oxaliplatin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]